Salzmann Peter

CIK 00017963092 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001796309

Recent Transactions

50 trades

Sale
Immunovant, Inc.$IMVT
Common Stock
2025-04-16$14.89/sh−8,321→ 1,178,191 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2025-04-09$12.99/sh−28,094→ 1,186,512 total
Award
Immunovant, Inc.$IMVT
Common Stock
2025-04-01+265,820→ 1,214,606 total
Award
Immunovant, Inc.$IMVT
Stock Option (right to buy)
2025-04-01+374,395→ 374,395 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2025-02-19$20.86/sh−15,439→ 948,786 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2025-01-15$24.19/sh−415→ 964,225 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2025-01-15$23.81/sh−8,352→ 964,640 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2025-01-08$24.10/sh−5,105→ 972,992 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2024-11-20$25.45/sh−16,692→ 978,097 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2024-10-16$28.79/sh−9,095→ 994,789 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2024-10-09$29.56/sh−4,460→ 1,003,884 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2024-08-21$31.84/sh−14,470→ 1,008,942 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2024-08-21$32.32/sh−598→ 1,008,344 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2024-07-17$30.55/sh−510→ 1,023,412 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2024-07-17$29.64/sh−8,175→ 1,023,922 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2024-07-09$28.06/sh−4,619→ 1,032,097 total
Award
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Common Stock, par value $0.0001 per share
2024-05-30+2,783→ 2,783 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2024-05-22$29.65/sh−16,163→ 1,036,716 total
Award
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Stock Option (right to buy)
2024-05-16+2,783→ 2,783 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2024-04-17$29.94/sh−7,714→ 1,052,879 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2024-04-17$28.80/sh−26,365→ 1,060,593 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2024-04-09$31.18/sh−4,807→ 1,086,958 total
Award
Immunovant, Inc.$IMVT
Common Stock
2024-04-02+160,534→ 1,091,765 total
Award
Immunovant, Inc.$IMVT
Stock Option (right to buy)
2024-04-02+200,667→ 200,667 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2024-02-22$36.15/sh−13,454→ 931,231 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2024-01-05$38.59/sh−3,824→ 944,685 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2023-11-22$33.52/sh−616→ 948,509 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2023-11-22$32.75/sh−15,601→ 949,125 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2023-10-05$36.39/sh−4,345→ 964,726 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2023-10-05$35.54/sh−894→ 969,071 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2023-08-30$22.48/sh−5,908→ 969,965 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2023-08-30$21.97/sh−50,866→ 975,873 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2023-08-14$21.34/sh−91,744→ 1,038,053 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2023-08-14$22.04/sh−11,314→ 1,026,739 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2023-08-07$21.73/sh−101,339→ 1,129,797 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2023-07-12$19.73/sh−3,233→ 1,231,136 total
Award
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Stock Option (right to buy)
2023-05-18+5,300→ 5,300 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2023-04-18$15.27/sh−3,395→ 1,234,369 total
Award
Immunovant, Inc.$IMVT
Common Stock
2023-04-12+243,832→ 1,237,764 total
Award
Immunovant, Inc.$IMVT
Stock Option (right to buy)
2023-04-12+316,585→ 316,585 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2023-01-11$16.80/sh−4,021→ 993,932 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2022-10-13$9.18/sh−2,793→ 997,953 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2022-09-28$4.67/sh−1,605→ 1,000,746 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2022-08-30$5.83/sh−1,644→ 1,002,351 total
Award
Immunovant, Inc.$IMVT
Common Stock
2022-08-17+451,264→ 1,003,995 total
Award
Immunovant, Inc.$IMVT
Stock Option (right to buy)
2022-08-17+678,592→ 678,592 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2022-07-27$4.27/sh−1,528→ 552,731 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2022-06-29$4.02/sh−1,376→ 554,259 total
Sale
Immunovant, Inc.$IMVT
Common Stock
2022-05-24$3.79/sh−1,471→ 555,635 total
Award
Corbus Pharmaceuticals Holdings, Inc.$CRBP
Stock Option(right to buy)
2022-05-18+79,600→ 79,600 total

Companies

Recent Filings

Address

C/O IMMUNOVANT, INC. 320 W 37TH STREET, 6TH FLOOR

NEW YORK, NY, 10018

View on SEC.gov